Overview
End-stage renal failure (ESRF) necessitates renal replacement therapy, with renal transplantation offering the best long-term outcomes compared to dialysis modalities. Post-transplant management focuses on preventing graft rejection and managing comorbidities.Diagnosis
Assessment of renal function through serum creatinine, urea levels, and estimated glomerular filtration rate (eGFR).
Evaluation of anemia, electrolyte imbalances, and acid-base status.
Imaging studies (e.g., ultrasound) to assess native kidneys and potential transplant anatomy.Management
First-line treatments:
- Renal transplantation for eligible patients [implied, no specific abstract].
- Hemodialysis or peritoneal dialysis as bridge therapy before transplant 13.
Adjunctive treatments:
- Antimicrobials with dialyzable agents like mecillinam (clearance rate 118.8 +/- 14.4 ml/min) for infections 2.
- Management of electrolyte balance, particularly crucial in hemofiltration 3.Special Populations
Comorbidities:
- Hemodialysis preferred in patients with dialysis discomfort, resistant hypertension, or polyneuropathy 3.Key Recommendations
Utilize peritoneal dialysis with conventional lactate-containing solutions sterilized by ultrafiltration for effective metabolic acidosis and azotemia management in ESRF patients awaiting transplant (Evidence: Moderate) 1.
Consider hemofiltration as a safe long-term treatment option for ESRF, with heightened attention to electrolyte balance compared to hemodialysis (Evidence: Moderate) 3.
Prefer hemodialysis over other modalities in patients presenting with specific complications such as dialysis discomfort, resistant hypertension, or polyneuropathy (Evidence: Moderate) 3.References
1 Ing TS, Yu AW, Thompson KD, Ansari AU, McShane AP, Gandhi VC et al.. Peritoneal dialysis using conventional, lactate--containing solution sterilized by ultrafiltration. The International journal of artificial organs 1992. link
2 el-Guinedy M, el Said W, Sabbour MS. Dialyzability of cefotaxime and mecillinam. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy 1986. link
3 Streicher E, Schneider H. Clinical experience in hemofiltration. The International journal of artificial organs 1980. link